Anticancer effects of small-molecule inhibitor CFAK-Y15 even more pronounced as part of combination therapy
Friday, December 21, 2012
BUFFALO, NY — Researchers from Roswell Park Cancer Institute (RPCI) have published findings from a preclinical study assessing the effectiveness of a small-molecule inhibitor, CFAK-Y15, in treating some brain cancers. The paper, published in Molecular Cancer Therapeutics, demonstrates for the...
Scholarship awarded to RPCI employee in tribute to Buffalo’s first African-American nurse
Wednesday, December 12, 2012
BUFFALO, NY — DeMarco Ogletree, a cashier in the Nutrition & Food Service Department at Roswell Park Cancer Institute (RPCI), earned the $2,000 Eva M. Noles Scholarship Friday, December 7 at the fifth annual Eva M. Noles Scholarship and Community Recognition Breakfast at RPCI. The annual...
RPCI is only facility in New York state to earn designation
Tuesday, December 4, 2012
BUFFALO, NY — Roswell Park Cancer Institute (RPCI) has been named to The Leapfrog Group’s annual Top Hospitals list for a third consecutive year. One of only three National Cancer Institute-designated comprehensive cancer centers in New York state, RPCI is the only New York facility to...